GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanadaBis Capital Inc (TSXV:CANB) » Definitions » EBIT

CanadaBis Capital (TSXV:CANB) EBIT : C$0.76 Mil (TTM As of Oct. 2024)


View and export this data going back to 2017. Start your Free Trial

What is CanadaBis Capital EBIT?

CanadaBis Capital's earnings before interest and taxes (EBIT) for the three months ended in Oct. 2024 was C$0.44 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Oct. 2024 was C$0.76 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. CanadaBis Capital's annualized ROC % for the quarter that ended in Oct. 2024 was 12.49%. CanadaBis Capital's annualized ROC (Joel Greenblatt) % for the quarter that ended in Oct. 2024 was 13.35%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. CanadaBis Capital's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Oct. 2024 was 4.03%.


CanadaBis Capital EBIT Historical Data

The historical data trend for CanadaBis Capital's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanadaBis Capital EBIT Chart

CanadaBis Capital Annual Data
Trend Nov16 Dec17 Dec18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
EBIT
Get a 7-Day Free Trial Premium Member Only -5.07 -2.28 1.10 5.01 1.19

CanadaBis Capital Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.25 0.24 -0.16 0.44

Competitive Comparison of CanadaBis Capital's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanadaBis Capital's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where CanadaBis Capital's EV-to-EBIT falls into.


';

CanadaBis Capital EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.76 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CanadaBis Capital  (TSXV:CANB) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

CanadaBis Capital's annualized ROC % for the quarter that ended in Oct. 2024 is calculated as:

ROC % (Q: Oct. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jul. 2024 ) + Invested Capital (Q: Oct. 2024 ))/ count )
=1.676 * ( 1 - 0% )/( (12.866 + 13.961)/ 2 )
=1.676/13.4135
=12.49 %

where

Note: The Operating Income data used here is four times the quarterly (Oct. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

CanadaBis Capital's annualized ROC (Joel Greenblatt) % for the quarter that ended in Oct. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Oct. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jul. 2024  Q: Oct. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1.744/( ( (10.545 + max(1.966, 0)) + (10.428 + max(3.193, 0)) )/ 2 )
=1.744/( ( 12.511 + 13.621 )/ 2 )
=1.744/13.066
=13.35 %

where Working Capital is:

Working Capital(Q: Jul. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.985 + 9.262 + 0.719) - (10 + 0 + 1.7763568394003E-15)
=1.966

Working Capital(Q: Oct. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3.011 + 11.175 + 0.542) - (11.535 + 0 + 0)
=3.193

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Oct. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

CanadaBis Capital's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Oct. 2024 )
=0.756/18.765
=4.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CanadaBis Capital EBIT Related Terms

Thank you for viewing the detailed overview of CanadaBis Capital's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


CanadaBis Capital Business Description

Traded in Other Exchanges
Address
255C Clearview Drive, Red Deer County, Red Deer, AB, CAN, T4E 3B6
CanadaBis Capital Inc is a vertically integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extract. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premises owned and operated by the Company. Extract segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extract Segment.
Executives
Garfield Richards Senior Officer
Shane Chana Director

CanadaBis Capital Headlines

From GuruFocus

Can B Corp.'s Pure Health Products Awarded NSF's GMP Certification

By GuruFocusNews GuruFocusNews 12-30-2021